Does muscle loss occur in people taking GLP-1 receptor agonists such as semaglutide (marketed as "Ozempic" and "Wegovy") or combined GLP-1/GIP agonists like tirzepatide (marketed as "Mounjaro")? In this episode, we discuss current evidence regarding these next-generation weight loss drugs and muscle wasting, as well as principles of preventing muscle loss in weight loss programs.

#healthspan, #ozempic, #fitness, #muscle, #science

Chapters:

00:00 - Intro
00:30 - Importance of Muscle in Weight Loss
01:19 - Muscle Loss During Weight Loss
02:03 - What Affects Muscle Mass During Weight Loss?
02:16 - Clinical Trials
04:59 - Preserving Muscle During Weight Loss
05:30 - Protein Intake
06:28 - Strength Training
06:59 - Monitoring Body Composition
07:26 - Summary

Social & Website:
Instagram - https://www.instagram.com/sterlingmdphd
Twitter - https://twitter.com/sterlingmdphd
Facebook - https://www.facebook.com/sterlingmdphd
TikTok - https://www.tiktok.com/@sterlingmdphd
Newsletter - http://eepurl.com/hQpdqT

Subscribe to the Podcast:
Apple Podcasts: https://apple.co/3y438C9
Spotify: https://open.spotify.com/show/5TDUK3F2sJXfnG63hSxJhT?si=40bb52e5b53f404c
Google Podcasts: https://bit.ly/3Olanei

References & Show Notes:
http://www.nicksterling.com/

The content of this video is for general information purposes only and does not constitute the practice of medicine or any other healthcare professional services. The content of this video is not medical advice. No doctor-patient relationship is formed. The content of this video should not take precedence over information provided to you by your healthcare provider or official public health sources. Please visit nicksterling.com/terms for full Terms of Use.